Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited Post published:October 24, 2022 Post category:Press Release
Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II Post published:January 20, 2022 Post category:Press Release
Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology Post published:January 11, 2021 Post category:Press Release
Eleusis Launches Clinical Development of Psychedelic Infusion Therapies for Major Depressive Disorder and Acquires Kalypso Wellness Centers Post published:December 14, 2020 Post category:Press Release
LSU Health Foundation, New Orleans and Foundation Board of Directors Announce Strategic Investment to Support Prevention and Treatment of Inflammatory Eye Disease Post published:September 6, 2020 Post category:Press Release
Interview with Shlomi Raz, CEO and Chairman of Eleusis Post published:June 3, 2020 Post category:Interview